Akebia Therapeutics Inc (NASDAQ:AKBA)
| 1.14 Delayed Data As of Oct 02 |  0.00 / 0.00%Today’s Change | 0.24 Today|||52-Week Range 1.84 | +97.57% Year-to-Date |
Latest AKBA News | Press Releases
No recent news for Akebia Therapeutics Inc.
Today’s Trading
| Previous close | 1.14 |
| Today’s open | 1.12 |
| Day’s range | 1.11 - 1.16 |
| Volume | 32,155 |
| Average volume (3 months) | 1,851,091 |
| Market cap | $212.8M |
Data as of 3:59pm ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | +69.75% |
| Earnings growth (this year) | +46.08% |
| Earnings growth (next 5 years) | +15.80% |
| Revenue growth (last year) | +36.94% |
| P/E ratio | NM |
| Price/Sales | 0.36 |
| Price/Book | 39.79 |
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $292.5M |
| Annual profit (last year) | -$94.2M |
| Net profit margin | -32.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
